Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

36.05
-0.3900-1.07%
Post-market: 36.900.8500+2.36%19:30 EDT
Volume:5.78M
Turnover:207.97M
Market Cap:42.00B
PE:60.08
High:36.33
Open:36.17
Low:35.62
Close:36.44
52wk High:38.37
52wk Low:18.14
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.36
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.42
PE(LYR):29.79

Loading ...

Teva Earnings Call Highlights Innovative-Driven Margin Upswing

TIPRANKS
·
May 06

Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its Strong Multi Year Rally?

Simply Wall St.
·
May 06

Top Teva Executives Quietly Offload Major Stock Stakes

TIPRANKS
·
May 05

Leader Capital Markets Remains a Buy on Teva (TEVA)

TIPRANKS
·
May 01

Teva Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 30

Truist Raises Price Target on Teva Pharmaceutical Industries to $45 From $42, Keeps Buy Rating

MT Newswires Live
·
Apr 30

Piper Sandler Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Apr 30

A Look At Teva (TEVA) Valuation After Strong Q1 2026 Earnings And Biosimilar Pipeline Progress

Simply Wall St.
·
Apr 30

Teva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside

TIPRANKS
·
Apr 30

Teva price target raised to $45 from $42 at Truist

TIPRANKS
·
Apr 30

Stock Track | Teva Pharmaceutical Soars 12.02% Intraday on Strong Q1 Earnings Beat and Emalex Acquisition

Stock Track
·
Apr 29

Sector Update: Health Care

MT Newswires Live
·
Apr 29

Teva Pharmaceuticals Exec Says Co's Operations Remain Uninterrupted With No Material Impact on 2026 Guidance - Conf Call

THOMSON REUTERS
·
Apr 29

Teva Pharmaceuticals Exec Says It Is Difficult to Predict Whether There Will Be a Channel Drawdown Ahead of Price Changes Set to Take Effect in 2027

THOMSON REUTERS
·
Apr 29

Teva Pharmaceuticals Exec Says Co Is Seeing Nominal Increases in Some Transportation and Energy Costs Related to Middle East Conflict

THOMSON REUTERS
·
Apr 29

Teva Pharmaceuticals Exec Says Co Continue to Monitor Geopolitical Situation in the Middle East - Conf Call

THOMSON REUTERS
·
Apr 29

Teva reports Q1 EPS 53c, consensus 46c

TIPRANKS
·
Apr 29

Teva Pharmaceutical Beats First-Quarter Profit Estimates On Branded Drugs Demand

Reuters
·
Apr 29

GUIDANCE: (TEVA) Teva Pharmaceutical Industries Expects 2026 Non-GAAP EPS Range $1.91 - 2.11

MT Newswires Live
·
Apr 29

Stock Track | Teva Pharmaceutical Soars 5.41% in Pre-Market on Strong Q1 Earnings Beat and Emalex Acquisition

Stock Track
·
Apr 29